Coumadin®
Warfarin is a vitamin K antagonist oral anticoagulant. Despite the emergence of DOACs, it remains essential for patients with mechanical heart valves.
| Dosage Form | Oral Tablet |
| Strength | 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg, 10 mg |
| Storage | Store at 15–30°C. Protect from light. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Venous thromboembolism; atrial fibrillation; mechanical heart valves; post-MI thromboprophylaxis.
Inhibits vitamin K epoxide reductase (VKORC1), preventing the regeneration of vitamin K and reducing hepatic synthesis of clotting factors II, VII, IX, and X.
Each Burrard Pharmaceuticals technology transfer package for Warfarin includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier templates — available through Burrard Intelligence subscription.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Our team can deliver the complete know-how package within 2–21 business days. Book a consultation to discuss your specific requirements.